Ovarian Cancer
Studies from M.L. Puiffe and co-researchers in the area of ovarian cancer published
Published in Cancer Weekly, February 5th, 2008
"At least one third of all cases of epithelial ovarian cancer are associated with the production of ascites, although its effect on tumor cell microenvironment remains poorly understood. This study addresses the effect of the heterologous acellular fraction of ovarian cancer - derived ascites on a cell line (OV-90) derived from the chemotherapy- nai ve ovarian cancer patient," scientists writing in the journal Neoplasia report.
"Ascites were assayed for their effect on cell invasion, growth, and spheroid formation. When compared to either no serum or 5% serum, ascites fell into one of two categories: stimulatory or inhibitory. RNA from OV- 90 cells exposed to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-02-05)
More Articles from Cancer Weekly
- Cancer Vaccines
Newly discovered virus linked to deadly skin cancer - Better Health Publishing
Breakthrough Study Links Prostate Cancer, Depression, IBS, Adrenal Fatigue and Allergies to Lead and Mercury Toxic Load in Body - Biophysics
New biophysics study findings recently were reported by J.M. Escoffre and co-researchers - Cancer Gene Therapy
Study data from Sichuan University provide new insights into cancer gene therapy - Cancer Vaccines
Research from A. Pallecarosa et al has provided new information about cancer vaccines - Cancer Vaccines
Research from S.I. Liu and co-researchers yields new findings on cancer vaccines - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
